Boxed warning
Tamper evident:Do not use if safety seal is broken or missing
Tamper evident:Do not use if safety seal is broken or missing
Other information store at room temperature 15˚-30˚C (59˚-86˚F) protect from humidity
Active ingredient (in each tablet)
Meclizine HCL 25 mg
Purpose
Antiemetic
Uses
For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness
Warnings
Do not use in children under 12 years of age unless directed by a doctor.
Ask a doctor before use if you have
• glaucoma
• breathing problems, such as emphysema or chronic bronchitis
• difficulty urinating due to an enlarged prostate gland
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
When using this product
• drowsiness may occur
• avoid alcoholic beverages
• alcohol, sedatives and tranquilizers may increase drowsiness
• use caution when driving a motor vehicle or operating machinery
If pregnant or breast-feeding,ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
Adults and children 12 years of age and older: Take 1-2 tablets once daily, or as directed by a doctor. Do not exceed 2 tablets in 24 hours.
Other information
Inactive ingredients: D&C yellow # 10 lake, lactose monohydrate, magnesium stearate, microcrystalline cellulose, colloidal silicon dioxide.
Questions or Comments?
Call 1-855-642-2594
Tamper evident:Do not use if safety seal is broken or missing
Comapre to active ingredient in DRAMAMINE ® ALL DAY LESS DROWSY*
*This product is not manufactured or distributed by the owner of registered trademark of DRAMAMINE ®
MADE IN USA
Manufactured by:
APNAR PHARMA LLP
East Windsor, NJ 08520
Rev.:10/2022
NDC 24689-146-01
Meclizine HCL 25 mg
Antiemetic
100 Tablets
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24689-146-01 | Meclizine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 2 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 24689-146-01 | EA - Each | 24689-146 | 3e171323-9e53-4ba0-b1a2-09648d23e598 | 1 | 2023-02-06 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 24689-146 | 24689-146-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| D&C YELLOW NO. 10 | 35SW5USQ3G | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | APNAR PHARMA LP | ed43bf21-f3da-245c-e053-2995a90a504c | 2025-01-09 | Boxed warning, Warnings | 24689-146-01 24689-146 24689014601 2b4a3632-89d2-8d7d-e063-6294a90a71e1 ed43bf21-f3da-245c-e053-2995a90a504c |
Adverse event summaries are temporarily unavailable. Other product information remains available.